Core-004
Core-004
批准号:
10662365
负责人:
Sallie R. Permar
金额:
$20.43万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-07-24 至 2025-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT – Statistics and Mathematical Modeling Core (Core 4)
The Statistics and Mathematical Modeling Core (Core 4) will provide data management, statistical analysis
and mathematical modeling support for the Program’s overall goal to understand the immunological and viral
determinants of congenital CMV infection. The Core has worked with both projects to define a comprehensive
sample size analysis for all experiments and will also analyze the data generated from those experiments to
identify correlates of placental transmission and viral load using descriptive statistics and statistical
visualization as well as univariate and multivariate regression modelling. Special attention is paid to the use of
use of methods that optimize information extraction from small sample sizes in both the experimental design
and subsequent analysis. An innovative aspect of the Core is the proposed development of mathematical
models and computer simulations to explore how different mechanistic assumptions affect viral population
growth and the likelihood of placental transmission under different immune control scenarios. These
mathematical models will take advantage of and integrate the viral population genetics analyses (Core 3), host
(Core 1) and CMV (Core 2) longitudinal measurements, and systematic experimental perturbations in naïve
and non-naïve hosts (Projects 1 and 2) to evaluate and generate hypotheses about how host-CMV
interactions modulate the risk of viral dissemination and placental transmission. The pharmacokinetics effort
within the Core will develop a semi-physiologic based PK model to characterize the maternal, fetal, and
maternal-fetal distribution of HIG after administration to RhCMV-infected rhesus dams or directly to RhCMVinfected fetuses to generate optimal dosing regimens of HIG for materno-fetal prevention and treatment of
congenital CMV. Core 4 will also work with the Admin Core to define the schema to capture critical data
summaries in a REDCap database, create templates to track versioning and experimental metadata in the
Duke Box service used for data sharing across projects and cores. Finally, Core 4 will work with the Admin
Core and in consultation with the Duke Office of Advancing Scientific Integrity, Services, and Training (ASIST)
to establish Program-specific data management SOPs and Scientific Culture and Accountability Plan (SCAP)
for the Program. Core 4 supports all components in this Program (Project 1, 2; Core 1, 2, 3; Admin Core),
and provides a centralized resource for exploratory data analysis, statistical analysis, pharmacokinetics
studies, mathematical modeling, and data management. Core 4 will be central to the preparation of all Program
presentations, reports, and manuscripts that seek to establish the immunologic and virologic factors involved in
placental transmission of CMV as a strategy to guide future vaccine design and evaluation
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
-
批准号:10677439
-
项目类别:
-
资助金额:$84.84万
-
财政年份:2023
-
负责人:Sallie R. Permar
-
依托单位:
Pediatric Scientist Development Program
-
批准号:10619351
-
项目类别:
-
资助金额:$153.57万
-
财政年份:2022
-
负责人:Sallie R. Permar
-
依托单位:
Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission
-
批准号:10327003
-
项目类别:
-
资助金额:$74.42万
-
财政年份:2021
-
负责人:Sallie R. Permar
-
依托单位:
Pediatric Scientist Development Program
-
批准号:10349771
-
项目类别:
-
资助金额:$87.5万
-
财政年份:2020
-
负责人:Sallie R. Permar
-
依托单位:
Pediatric Scientist Development Program
-
批准号:10220089
-
项目类别:
-
资助金额:$140.96万
-
财政年份:2020
-
负责人:Sallie R. Permar
-
依托单位:
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
-
批准号:10223633
-
项目类别:
-
资助金额:$13.75万
-
财政年份:2020
-
负责人:Sallie R. Permar
-
依托单位:
Project-003
-
批准号:10461206
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core-001
-
批准号:10461201
-
项目类别:
-
资助金额:$28.0万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Project-003
-
批准号:10441007
-
项目类别:
-
资助金额:$25.81万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core-004
-
批准号:10441005
-
项目类别:
-
资助金额:$16.83万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Project 1: Immune correlates of cCMV
-
批准号:10215784
-
项目类别:
-
资助金额:$0.19万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core 2: Virology, Molecular, and Histology Core
-
批准号:10215781
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core 3: Genomic Sequencing and Population Genetics Core
-
批准号:10215782
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Immunologic and virologic determinants of congenital Cytomegalovirus transmission and disease in rhesus monkeys
-
批准号:10402416
-
项目类别:
-
资助金额:$294.82万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core 3: Genomic Sequencing and Population Genetics Core
-
批准号:10374246
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core 2: Virology, Molecular, and Histology Core
-
批准号:10374245
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core-001
-
批准号:10441002
-
项目类别:
-
资助金额:$108.26万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Project-002
-
批准号:10662366
-
项目类别:
-
资助金额:$50.91万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Project-003
-
批准号:10662367
-
项目类别:
-
资助金额:$25.27万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
Core-003
-
批准号:10461203
-
项目类别:
-
资助金额:$14.17万
-
财政年份:2019
-
负责人:Sallie R. Permar
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新型蒽酚类化合物XYD004通过激活AHR缓解银屑病的作用及机制研究
-
批准号:2025JJ60573
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:蒋骞
-
依托单位:
tiRNA-Val-TAC-004在胃癌进展中的作用机制及标志物价值研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:付敏
-
依托单位:
环状RNA hsa_circSERPINE2_004介导MSC衰老在老年性骨质 疏松症发病中的作用及其机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:旺姗
-
依托单位:
ADRQβ-004疫苗靶向α1D-AR调节交感神经失衡与改善肺动脉重构的机制研究
-
批准号:82070522
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:邱志华
-
依托单位:
CsERF004调控黄瓜双抗性分子机制的研究
-
批准号:31801871
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:刘东
-
依托单位:
Snail/p53结合抑制剂SN004的抗肿瘤作用及分子机制研究
-
批准号:81803033
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:李红玫
-
依托单位:
以CKLF1为新型药物靶标的发现及其抗缺血性损伤的系统性药理学研究
-
批准号:81730096
-
项目类别:重点项目
-
资助金额:290.0万元
-
批准年份:2017
-
负责人:陈乃宏
-
依托单位:
SMIP004/SMIP004-7系列线粒体抑制剂作用机制及应用于去势抵抗性前列腺癌治疗的潜力研究
-
批准号:81773771
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2017
-
负责人:Dieter A. Wolf
-
依托单位:
新型脑保护剂H004及其活性葡萄糖醛酸代谢产物的脑转运代谢机制及药代-药效学研究
-
批准号:81603190
-
项目类别:青年科学基金项目
-
资助金额:17.3万元
-
批准年份:2016
-
负责人:盛莉
-
依托单位:
木质纤维素水解液中抑制剂对发酵性丝孢酵母T.fermentans HWZ004细胞生长和油脂积累的影响规律及其机理研究
-
批准号:31071559
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2010
-
负责人:吴虹
-
依托单位: